Shanghai Aidu Biotechnology is a premier, research-driven manufacturer specializing in nutraceutical ingredients. With over a decade of expertise and a state-of-the-art R&D center equipped with advanced LC-MS/GC-MS technology, we provide premium ingredients for the global pharmaceutical, nutraceutical, and cosmetic industries. As a market leader in anti-aging & longevity ingredients, Aidu Biotech ensures superior quality and seamless supply chain reliability through our self-owned production facilities and strategic US-based warehousing.Click Here to Learn More.
Strategic Footprint
Integrated Global Supply Chain: From Scientific Innovation to Industrial Scale.
Aidu Biotech has established a powerful, synergized network that seamlessly bridges advanced research with large-scale industrialization.
Through this integrated "Shanghai-Sichuan-USA" architecture, we have mastered the entire lifecycle—from R&D and raw material procurement to advanced manufacturing and final delivery. This end-to-end capability allows us to significantly shorten the innovation-to-market cycle, offering our clients unparalleled supply chain resilience and competitive advantage.
Innovation Hub in Shanghai: Our global headquarters, strategically located in the heart of Shanghai’s CBD, serves as the brain for strategic decision-making, global sales, and front-end innovation.
Industrial Anchor in Sichuan: We operate a massive 130,000-square-meter state-of-the-art production facility in Sichuan, China. This hub is powered by a dedicated team of elite research technicians and engineers, ensuring that every batch meets the highest standards of purity and consistency.
Localized Supply in Los Angeles: To ensure seamless global delivery, we maintain a dedicated local warehouse in Los Angeles, USA, providing our North American partners with immediate stock availability and significantly reduced lead times.
NAD+ Category Sees an Evolution: NMNH Disrupts the Global Market with a 20.7% CAGR
The global NMNH market is projected to reach $146.1M by 2032 with a 20.7% CAGR. As a potent reduced form of NMN , it delivers a 4–5x NAD⁺ boost (vs. NMN's ~2x) and peaks in just 15–30 minutes. Backed by GRAS status and lower production costs , premium brands are rapidly shifting to NMNH. Aidu Bio provides B2B-grade high-purity NMNH powder (≥99%) with full COA.
Shanghai Aidu Biotechnology has completed an overseas shipment of its proprietary ProFisetin®, along with β-NMN and β-NAD+. ProFisetin® is supported by zebrafish model data and third-party testing, ensuring high purity and traceability for the global nutraceutical and sports nutrition industries. The company remains committed to providing stable, science-backed ingredient solutions to its international partners.
Beyond the Gym: Creatine Monohydrate Emerges as a New Growth Pole in Brain Health
The global creatine monohydrate market is projected to skyrocket to USD 659 million by 2031 with a 10.5% CAGR. Driven by a 2024 landmark systematic review in Frontiers in Nutrition, creatine is gaining recognition for its significant benefits in memory and information processing speed. As the "Muscle-Brain Axis" hypothesis gains traction, creatine is transitioning into a foundational health component for students, professionals, and healthy aging.
2026 Liver Health Milestone: Meta-Analysis Confirms DHM’s Metabolic Potential
According to a landmark 2026 meta-analysis in Frontiers in Nutrition, Dihydromyricetin (DHM) significantly improves liver function biomarkers and activates the AMPK pathway. As the market reaches $1.5B, DHM is becoming a cornerstone for metabolic health formulations.
From the Gym to the Office: In 2026, Creatine Is Redefining the Global
Creatine is no longer exclusively for athletes. With the rise of biohacking and longevity awareness, highly stable, bioavailable creatine is becoming a core ingredient in nootropic and anti-aging formulations. This article explores the 11% increase in brain energy reserves and the technical solutions for stable RTDs and gummies provided by Shanghai Aidu Biotechnology.
